LYMPHOBLASTIC LEUKEMIA
Clinical trials for LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost leukemia treatment
Disease control OngoingThis early-phase study tests whether adding a short course of the drug dasatinib can make CAR T-cell therapy more manageable for adults with relapsed or refractory B-cell acute lymphoblastic leukemia. Eight participants receive dasatinib pills for three days each week during the …
Matched conditions: LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 17, 2026 05:06 UTC
-
New drug combo aims to wipe out leukemia without chemo
Disease control TerminatedThis study tests adding the drug inotuzumab ozogamicin (InO) to standard treatment for adults newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The goal is to see if this chemotherapy-free approach leads to faster and deeper remission, …
Matched conditions: LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 14, 2026 12:03 UTC